|
1
|
Edwards BK, Noone AM, Mariotto AB, Simard
EP, Boscoe FP, Henley SJ, Jemal A, Cho H, Anderson RN, Kohler BA,
et al: Annual Report to the Nation on the status of cancer,
1975–2010, featuring prevalence of comorbidity and impact on
survival among persons with lung, colorectal, breast, or prostate
cancer. Cancer. 120:1290–1314. 2014. View Article : Google Scholar
|
|
2
|
Wang Y and Liu Y, Malek SN, Zheng P and
Liu Y: Targeting HIF1α eliminates cancer stem cells in
hematological malignancies. Cell Stem Cell. 8:399–411. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Luo W, Hu H, Chang R, Zhong J, Knabel M,
O'Meally R, Cole RN, Pandey A and Semenza GL: Pyruvate kinase M2 is
a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell.
145:732–744. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mak P, Leav I, Pursell B, Bae D, Yang X,
Taglienti CA, Gouvin LM, Sharma VM and Mercurio AM: ERbeta impedes
prostate cancer EMT by destabilizing HIF-1alpha and inhibiting
VEGF-mediated snail nuclear localization: Implications for Gleason
grading. Cancer Cell. 17:319–332. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Swietach P, Vaughan-Jones RD and Harris
AL: Regulation of tumor pH and the role of carbonic anhydrase 9.
Cancer Metastasis Rev. 26:299–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan DA and Giaccia AJ: Hypoxia, gene
expression, and metastasis. Cancer Metastasis Rev. 26:333–339.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Semenza GL: Hypoxia-inducible factors in
physiology and medicine. Cell. 148:399–408. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang H, Wong CCL, Wei H, Gilkes DM,
Korangath P, Chaturvedi P, Schito L, Chen J, Krishnamachary B,
Winnard PT Jr, et al: HIF-1-dependent expression of
angiopoietin-like 4 and L1CAM mediates vascular metastasis of
hypoxic breast cancer cells to the lungs. Oncogene. 31:1757–1770.
2012. View Article : Google Scholar
|
|
9
|
Estecha A, Sánchez-Martín L, Puig-Kröger
A, Bartolomé RA, Teixidó J, Samaniego R and Sánchez-Mateos P:
Moesin orchestrates cortical polarity of melanoma tumour cells to
initiate 3D invasion. J Cell Sci. 122:3492–3501. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Poincloux R, Collin O, Lizárraga F, Romao
M, Debray M, Piel M and Chavrier P: Contractility of the cell rear
drives invasion of breast tumor cells in 3D Matrigel. Proc Natl
Acad Sci USA. 108:1943–1948. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dahan I, Yearim A, Touboul Y and Ravid S:
The tumor suppressor Lgl1 regulates NMII-A cellular distribution
and focal adhesion morphology to optimize cell migration. Mol Biol
Cell. 23:591–601. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vicente-Manzanares M, Ma X, Adelstein RS
and Horwitz AR: Non-muscle myosin II takes centre stage in cell
adhesion and migration. Nat Rev Mol Cell Biol. 10:778–790. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Clark K, Langeslag M, Figdor CG and van
Leeuwen FN: Myosin II and mechanotransduction: A balancing act.
Trends Cell Biol. 17:178–186. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Betapudi V: Myosin II motor proteins with
different functions determine the fate of lamellipodia extension
during cell spreading. PLoS One. 5:e85602010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Doyle AD, Kutys ML, Conti MA, Matsumoto K,
Adelstein RS and Yamada KM: Micro-environmental control of cell
migration - myosin IIA is required for efficient migration in
fibrillar environments through control of cell adhesion dynamics. J
Cell Sci. 125:2244–2256. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Z, van Grunsven LA, Van Rossen E,
Schroyen B, Timmermans JP, Geerts A and Reynaert H: Blebbistatin
inhibits contraction and accelerates migration in mouse hepatic
stellate cells. Br J Pharmacol. 159:304–315. 2010. View Article : Google Scholar :
|
|
17
|
Liu Z, Van Rossen E, Timmermans JP, Geerts
A, van Grunsven LA and Reynaert H: Distinct roles for non-muscle
myosin II isoforms in mouse hepatic stellate cells. J Hepatol.
54:132–141. 2011. View Article : Google Scholar
|
|
18
|
Betapudi V, Licate LS and Egelhoff TT:
Distinct roles of nonmuscle myosin II isoforms in the regulation of
MDA-MB-231 breast cancer cell spreading and migration. Cancer Res.
66:4725–4733. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao R, Sun L, Lin S, Bai X, Yu B, Yuan S
and Zhang L: The saponin monomer of dwarf lilyturf tuber, DT-13,
inhibits angio-genesis under hypoxia and normoxia via
multi-targeting activity. Oncol Rep. 29:1379–1386. 2013.PubMed/NCBI
|
|
20
|
Zhang YY, Liu JH, Kou JP, Yu J and Yu BY:
DT-13, a steroidal saponin from Liriope muscari L. H. Bailey,
suppresses A549 cells adhesion and invasion by inhibiting MMP-2/9.
Chin J Nat Med. 10:436–440. 2012.
|
|
21
|
Yu XW, Lin S, Du HZ, Zhao RP, Feng SY, Yu
BY, Zhang LY, Li RM, Qian CM, Luo XJ, et al: Synergistic
combination of DT-13 and topotecan inhibits human gastric cancer
via myosin IIA-induced endocytosis of egf receptor in vitro and in
vivo. Oncotarget. doi: 10.18632. 2016.
|
|
22
|
Schramek D, Sendoel A, Segal JP, Beronja
S, Heller E, Oristian D, Reva B and Fuchs E: Direct in vivo RNAi
screen unveils myosin IIa as a tumor suppressor of squamous cell
carcinomas. Science. 343:309–313. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Z, Ho CH and Grinnell F: The different
roles of myosin IIA and myosin IIB in contraction of 3D collagen
matrices by human fibroblasts. Exp Cell Res. 326:295–306. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Casalou C, Seixas C, Portelinha A, Pintado
P, Barros M, Ramalho JS, Lopes SS and Barral DC: Arl13b and the
non-muscle myosin heavy chain IIA are required for circular dorsal
ruffle formation and cell migration. J Cell Sci. 127:2709–2722.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Derycke L, Stove C, Vercoutter-Edouart AS,
De Wever O, Dollé L, Colpaert N, Depypere H, Michalski JC and
Bracke M: The role of non-muscle myosin IIA in aggregation and
invasion of human MCF-7 breast cancer cells. Int J Dev Biol.
55:835–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia ZK, Yuan YC, Yin N, Yin BL, Tan ZP and
Hu YR: Nonmuscle myosin IIA is associated with poor prognosis of
esophageal squamous cancer. Dis Esophagus. 25:427–436. 2012.
View Article : Google Scholar
|
|
27
|
Jorrisch MH, Shih W and Yamada S: Myosin
IIA deficient cells migrate efficiently despite reduced traction
forces at cell periphery. Biol Open. 2:368–372. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang H, Chen Y, Wadham C, McCaughan GW,
Keane FM and Gorrell MD: Dipeptidyl peptidase 9 subcellular
localization and a role in cell adhesion involving focal adhesion
kinase and paxillin. Biochim Biophys Acta. 1853:470–480. 2015.
View Article : Google Scholar
|
|
29
|
Babbin BA, Koch S, Bachar M, Conti MA,
Parkos CA, Adelstein RS, Nusrat A and Ivanov AI: Non-muscle myosin
IIA differentially regulates intestinal epithelial cell restitution
and matrix invasion. Am J Pathol. 174:436–448. 2009. View Article : Google Scholar : PubMed/NCBI
|
